GLP-1 Half-Life: How Long It Stays in Your System

“How long does Ozempic stay in your system?” is one of the most-searched GLP-1 questions, and people ask it for concrete reasons: an upcoming surgery, waiting for a side effect to settle, planning a pregnancy, or switching to a different drug. The answer comes straight from the FDA labels, which report each drug's elimination half-life — the time it takes the body to clear half of what's in the blood. For semaglutide (Ozempic, Wegovy, Rybelsus) the label states the half-life is “approximately 1 week,” and that semaglutide “will be present in the circulation for about 5 weeks after the last dose” ^[1]. Tirzepatide (Mounjaro, Zepbound) has a half-life of “approximately 5 days” ^[4]. The once-daily oral pill orforglipron (Foundayo) clears far faster — about 29 to 49 hours ^[6]. Below is a per-drug table, the pharmacology behind it, and what it means for surgery, side effects, pregnancy planning, and switching. One honest caveat up front: a drug being cleared from your blood is not the same as its appetite and weight effects being gone — those follow their own, slower timeline.

How long each GLP-1 stays in your system

Pharmacology uses a simple rule of thumb: after about 5 half-lives, roughly 97% of a drug has been eliminated and it is considered substantially cleared. Applying that rule to the half-life printed in each FDA label gives the practical “out of your system” window. The values below are quoted directly from the current DailyMed labels — none are estimated or recalled.

The pattern is clear: the once-weekly injectables (semaglutide, tirzepatide) are engineered to linger, which is exactly why they only need dosing every 7 days. The daily drugs — oral orforglipron and injectable liraglutide — clear within days. Note that oral Rybelsus, despite being a daily tablet, contains the same long-acting semaglutide molecule, so it behaves like the weekly injectables for clearance even though you take it every day.

The pharmacology: why weekly dosing works, and why effects linger

A long half-life is a design feature, not an accident. Semaglutide is bound tightly to albumin in the blood, which protects it from rapid breakdown and gives it the ~1-week half-life that allows once-weekly injection ^[2]. Because each dose is only half-cleared after a week, repeated weekly doses accumulate until the amount going in matches the amount being cleared — a plateau called steady state. The semaglutide label reports steady state is reached after 4 to 5 weeks of once-weekly dosing ^[1][3]; the tirzepatide label reports steady state after about 4 weeks ^[4]. This is why a GLP-1 takes several weeks to reach full effect when you start, and why the dose is titrated up slowly.

The same accumulation works in reverse when you stop. Because the drug clears over weeks (semaglutide) or days-to-weeks (tirzepatide), blood levels — and the direct appetite-suppressing effect — fade gradually rather than vanishing the day after your last dose. That gradual decline is usually a good thing: there is no abrupt “withdrawal” in the addiction sense, just a slow return of appetite as drug levels fall. The flip side is that if you stop because of a side effect, the side effect can persist for the same clearance window while the drug works its way out.

Practical scenario 1 — surgery and anesthesia

GLP-1 drugs slow stomach emptying, which raises the concern of retained food and aspiration during anesthesia. The relevant question before surgery is usually not “is it fully out of my system?” (which would mean ~5 weeks off semaglutide) but rather how to time the hold to reduce that specific risk. Current anesthesia guidance does not require waiting five half-lives; it generally focuses on holding the most recent weekly dose and assessing gut emptying — see our dedicated breakdown of the ASA / anesthesia guidance for GLP-1 patients before surgery. Always follow the specific instructions of your surgeon and anesthesiologist, because protocols differ by procedure and by whether you are on a daily versus weekly drug.

Practical scenario 2 — how long side effects last after stopping

If you stop a GLP-1 because of nausea, reflux, or other gut side effects, expect them to ease over the same window the drug takes to clear: roughly a few days for liraglutide or orforglipron, up to several weeks as semaglutide levels fall toward zero over ~5 weeks. Tirzepatide sits in between at roughly 3 weeks. Side effects typically improve steadily as blood levels decline rather than stopping overnight. Persistent or severe symptoms after the expected clearance window — or any severe abdominal pain — warrant medical review rather than simply waiting.

Practical scenario 3 — pregnancy planning

Because of the long half-life, the FDA labels advise stopping these drugs well before a planned pregnancy. The Wegovy label, for example, instructs discontinuing the drug “at least 2 months before” a planned pregnancy specifically “to account for the long half-life of semaglutide” ^[5]. This is a longer washout than simple blood clearance (~5 weeks) because it builds in a safety margin. The timing differs by drug, so we cover the specifics — including tirzepatide — in our GLP-1 pregnancy washout and preconception timing guide. Talk to your prescriber and obstetric clinician about your individual timeline.

Practical scenario 4 — switching between GLP-1s

When switching from one GLP-1 to another (for example semaglutide to tirzepatide), you generally don't wait for the first drug to fully clear — clinicians typically start the new drug at its lowest titration dose on the next scheduled dosing day, because the long half-lives mean there is no abrupt gap. The overlap as the old drug clears is expected and accounted for by starting low. The dose conversions and titration logic are drug-specific; see our guide to switching between GLP-1 medications for the practical steps and equivalence considerations.

“Cleared from your blood” is not “effects gone”

This is the most important nuance and the one most search results miss. The half-life tells you how fast the drug molecule leaves your bloodstream. It does not tell you how long the physiologic effects last. Appetite, food noise, and weight regulation are influenced by the drug while it is present, but once it clears, hunger and weight tend to drift back toward the pre-treatment baseline over weeks to months — a separate, slower process than blood clearance. In short, semaglutide may be substantially gone from your blood in ~5 weeks, but appetite and weight effects can rebound over a much longer horizon. We cover what to expect — and how to mitigate it — in what happens to your weight when you stop a GLP-1.

Bottom line

The weekly GLP-1s are built to last: semaglutide (Ozempic, Wegovy, Rybelsus) has an elimination half-life of about 1 week and is present in the circulation for about 5 weeks after the last dose ^[1], while tirzepatide (Mounjaro, Zepbound) has a half-life of about 5 days, clearing in roughly 3 weeks ^[4]. The daily drugs clear far faster — oral orforglipron (Foundayo) in about 6 to 10 days ^[6] and liraglutide in a few days ^[7]. Apply the standard 5-half-lives rule to those numbers and you have your practical “out of my system” window. Just remember that blood clearance and physiologic effect are two different clocks: the appetite and weight benefits taper on their own, slower schedule once the drug is gone.

This article is educational and is not medical advice. Every half-life value above is quoted directly from the current FDA prescribing information on DailyMed (SetIDs in the references), verified on 1 June 2026; the semaglutide pharmacokinetics review was verified against the live PubMed database. Individual clearance varies — interpret timing with your own clinician.